Research Articles | Page 12 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Pretransplantation Therapy with Hypomethylating Agents in Patients with Myelodysplastic Syndromes Receiving Reduced-Intensity Conditioning Regimens Jul 2014 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation Oct 2016 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes - Lingering Uncertainties and Emerging Possibilities Jul 2014 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes Mar 2017 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia May 2018 Biol Blood Marrow Transplant acute myeloid leukemia (AML)
Total Lymphoid Irradiation-Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms Mar 2014 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Striking the right balance: optimizing conditioning regimens for unrelated donor bone marrow transplant for severe aplastic anemia. May 2012 Biol Blood Marrow Transplant aplastic anemia
Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels Apr 2012 Biol Blood Marrow Transplant aplastic anemia
Long-term outcome of fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria May 2014 Biol Blood Marrow Transplant paroxysmal nocturnal hemoglobinuria (PNH)
Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to MDS or Leukemia from Severe Aplastic Anemia. A report by the MDS subcommittee of the chronic malignancies working party (CMWP) and the severe aplastic anemia working party (WPSAA) Jun 2014 Biol Blood Marrow Transplant aplastic anemia